Screener
Sionna Therapeutics SION Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Sionna Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Sionna Therapeutics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033876
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Cash and cash equivalents | $63,324 | $58,451 |
| Marketable securities, current | 152,826 | 177,431 |
| Prepaid expenses and other current assets | 4,809 | 5,537 |
| Total current assets | 220,959 | 241,419 |
| Property and equipment, net | 2,071 | 2,225 |
| Marketable securities, noncurrent | 73,781 | 74,420 |
| Restricted cash | 963 | 963 |
| Operating lease right-of-use asset | 6,680 | 6,926 |
Item 1. Financial Statements
FAQ
- What is Sionna Therapeutics's total current assets?
- Sionna Therapeutics (SION) reported total current assets of $220.96M in Q1 2026.
- How has Sionna Therapeutics's total current assets changed year-over-year?
- Sionna Therapeutics's total current assets decreased by 19.3% year-over-year, from $273.68M to $220.96M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Sionna Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude